News

The license comprises the patent application entitled ‘Identification of Ergothioneine Transporter and Therapeutic Uses Thereof.’ This transporter is present in human cells, especially red and white blood cells,

The 3T3-L1 system, which was originally derived from Swiss mouse embryo tissue by Dr Howard Green of the department of cell biology at Harvard Medical School, has been

Total product revenue was $70.2m, a 16% increase compared to $60.6m for the fourth quarter of 2008. Total product revenue for full year 2009 was $232.9m compared to

The expanded organization provides the biopharmaceutical industry with access to a global CRO that has its focus on the developmental phase between intellectual property (IP) and submission of

According to Cempra Pharma, CEM-101 is expected to be the first macrolide to have an intravenous formulation available in the US since intravenous azithromycin was approved in 1997,

GlycosBio has created a platform that can consume carbon from multiple non-sugar feedstock sources to produce a variety of chemical products. The approach not only eliminates the risk

GeNO said that the initial indication to be studied for nitric oxide delivered via the GeNO Nitrosyl delivery system is as a diagnostic agent for administration as an

The company is the maker of Vagisil brand feminine hygiene products and had been marketing Vagisil deodorant powder in a 7-oz bottle size. The company intended to come

Orphan-drug designation will be granted by the FDA Office of Orphan Drug Products Development to novel drugs or biologics that may treat a condition affecting less than 200,000